Диссертация (1140524), страница 22
Текст из файла (страница 22)
Biochemical andBiophysical Research /A.H. Minn, N.B. Patterson, S. Pack et al. // Communications. –2003. – Vol.310(2). – P.641–645.190. Mitchell, M. Adipokines: implications for female fertility and obesity /M.Mitchell, D.T. Armstrong, R.L. Robker // Reproduction. – 2005. – Vol.130. – P.583–97.191. Mittelman, S.D.
Extremeinsulin resistance of the central adiposedepot in vivo/S.D. Mittelman, G.W. Van Citters, E.L. Kirkman, R.N. Bergman // Diabetes. - 2002.- Vol.51 (3). - P.755-761.192. Mohammadi, E. Effects of omega-3 fatty acids supplementation on serumadiponectin levels and some metabolic risk factors in women with polycystic ovary137syndrome /E.
Mohammadi, M. Rafraf, L. Farzadi et al. // Asia Pac. J. Clin. Nutr. –2012. - Vol.21. – Р.511–518.193. Moore, A.M. Polycystic ovary syndrome: Understanding the role of the brain/A.M. Moore, R.E. Campbell // Front Neuroendocrinol. - 2017. - Vol.46. – Р.1-14.194. Moran, L. Weight management to improve outcomes in infertility /In: TarlatzisB.C., Bulun S.E., eds. Transforming reproductive medicine worldwide.
Birmingham: American Society for Reproductive Medicine, 2013. – Р.66–73.195. Moran, L.J. The use of anti-mullerian hormone in predicting menstrualresponse after weight loss in overweight women with polycystic ovary syndrome/L.J.Moran, M.Noakes, P.M. Clifton, R.J. Norman // J.
Clin. Endocrinol. Metab. –2007. - Vol.92(10). – Р.3796-3802.196. Morash, B.A. Pituitary resistin gene expression: effects of age, gender andobesity /B.A. Morash, E., G. Wiesner et al.// Neuroendocrinology. – 2004. –Vol.79(3). – P.149–156.197. Moreno-Aliaga, M.J. Regulation of adipokine secretion by n-3 fatty acids /M.J.Moreno-Aliaga, S. Lorente-Cebrian, J.A. Martinez// Proc Nutr Soc. – 2010. –Vol.69(3). – P.324–332.198. Morris, D.L.
Recent advances in understanding leptin signaling and leptinresistance /D.L. Morris, L. Rui // American Journal of Physiology. Endocrinology andMetabolism. – 2009. – Vol.297. – Vol.1247–1259.199. Motta, A.B. The role of obesity in the development of polycystic ovarysyndrome / A.B. Motta // Curr Pharm Des.
– 2012. – Vol.18(17). – P.2482-2491.200. Mu, N. Insulin resistance: a significant risk factor of endometrial cancer /N.Mu,Y. Zhu, Y. Wang et al.// Gynecol Oncol. – 2012. - Vol.125(3). – P.751-757.201. Muccioli, G. Beyond the metabolic role of ghrelin: a new player in theregulation of reproductive function /G. Muccioli, T. Lorenzi, M. Lorenzi // Peptides. –2011. – Vol.32(12). – P.2514-2521.138202.
Munir, I. Resistin stimulation of 17α-hydroxylase activity in ovarian theca cellsin vitro: relevance to polycystic ovary syndrome / I. Munir, H.W. Yen, T. Baruth et al.// Journal of Clinical Endocrinology and Metabolism.-2005. – Vol.90(8). – P.4852–4857.203. Murakami, N. Role for central ghrelin in food intake and secretion profile ofstomach ghrelin in rats /N.
Murakami, T. Hayashida, T.Kuroiwa et al. // J. Endocrinol.– 2002. – Vol.174(2). – P.283–288.204. Naderpoor, N. Metformin and lifestyle modification in polycystic ovarysyndrome: systematic review and meta-analysis /N. Naderpoor, S. Shorakae, B. deCourten et al. // Hum. Reprod. Update. - 2015. - Vol.21(5). – Р.560-574.205.
O’Brien, S.M. Impact of gender and menstrual cycle phase on plasma cytokineconcentrations/S.M.O’Brien,P.Fitzgerald,P.Scullyetal.//Neuroimmunomodulation. – 2007. – Vol.14. – P.84–90.206. Ogbuji, Q.C. Obesity and reproductive performance in women /Q.C. Ogbuji //Afr. J. Reprod. Health. – 2010. – Vol.14(3). – P.143-151.207. Ogden, C.L. Prevalence of obesity and trends in body mass index among USchildren and adolescents, 1999–2010 /C.L. Ogden, M.D. Carroll, B.K. Kit, K.M.Flegal // JAMA. – 2012.
- Vol.307. – Р.483–490.208. Ogura, K. Effects of leptin on secretion of LH and FSH from primary culturedfemale rat pituitary cells /K. Ogura, M.Irahara, M. Kiyokawa // Eur. J. Endocrinol. –2001. – Vol.144. – P.653–658.209. Ollila, M.M. Weight Gain and Dyslipidemia in Early Adulthood AssociateWith PolycysticOvarySyndrome: Prospective Cohort Study /M.M.
Ollila, T. Piltonen,K. Puukka et al. // J. Clin. Endocrinol. Metab. – 2016. - Vol.101(2). – P.739-747.210. Orio,F.Thecardiovascularriskofyoungwomenwithpolycysticovarysyndrome: an observational, analytical, prospective case-control study/F. Orio, S. Palomba, L. Spinelli et al.
// J. Clin. Endocrinol. Metab. – 2004. -139Vol.89(8). – Р.3696-3701.211. Oro´stica, L. Proinflammatory environment and role of TNF-alpha inendometrial function of obese women having polycystic ovarian syndrome /L.Oro´stica, I. Astorga, F. Plaza-Parrochia et al. // Int. J. Obes. (Lond). – 2016. Vol.40(11). – Р.1715-1722.212. Ouchi, N. Cardioprotection by adiponectin /N.
Ouchi, R. Shibata, K. Walsh //Trends Cardiovasc Med. – 2006. – Vol.16(5). – P.141–6.213. Ozgen, I.T. Characteristics of polycystic ovarian syndrome and relationshipwith ghrelin in adolescents /I.T. Ozgen, M. Aydin, A. Guven Y. Aliyazicıoglu // J.Pediatr. Adolesc. Gynecol. – 2010. - Vol.23(5). – Р.285-289.214. Ozler, S. The association of thiol/disulphide homeostasis and lipidaccumulation index with cardiovascular risk factors in overweight adolescents withpolycystic ovary syndrome /S. Ozler, E. Oztas, A. Tokmak et al.// Clin. Endocrinol.(Oxf).
– 2016. - Vol.84(4). – P.516-523.215. Patel, L. Resistin is expressed in human macrophages and directly regulated byPPARγ activators /L. Patel, A.C. Buckels, I.J. Kinghorn et al. // Biochemical andBiophysical Research Communications. – 2003. – Vol.300(2). – P.472–476.216. Payette, C. Sex differences in postprandial plasma tumor necrosis factor-alpha,interleukin-6, and C-reactive protein concentrations /C. Payette, P.
Blackburn, B.Lamarche et al. // Metabolism. – 2009. – Vol.58(11). – P.1593–1601.217. Pepene, C.E. Evidence for visfatin as an independent predictor of endothelialdysfunction in polycystic ovary syndrome /C.E. Pepene // Clin Endocrinol (Oxf). –2012. - Vol.76. – Р. 119–125.218. Petzel, M. Action of leptin on bone and its relationship to menopause /M.Petzel // Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
– 2007. –Vol.151(2). – P.195–199.140219. Phelan, N. Hormonal and metabolic effects of polyunsaturated fatty acids inyoung women with polycystic ovary syndrome: results from a cross-sectional analysisand a randomized, placebo-controlled, crossover trial /N. Phelan, A. O’Connor, T.Kyaw-Tun et al. // Am. J. Clin. Nutr. – 2011. - Vol.93.
– Р.652–662.220. Phelan, N. Lipoprotein subclass patterns in women with polycystic ovarysyndrome (PCOS) compared with equally insulin-resistant women without PCOS /N.Phelan, A. O’Connor, T. Kyaw-Tun et al.// J Clin Endocrinol Metab. – 2010. Vol.95. – P.3933.221.
Pietilainen, K.H. Acquired obesity increases CD68 and tumor necrosis factor-αand decreases adiponectin gene expression in adipose tissue: a study in monozygotictwins /K.H. Pietilainen, K.H Kannisto, E. Korsheninnikova // Journal of ClinicalEndocrinology and Metabolism. – 2006.
– Vol.91. – P.2776–2781.222. Pisto, P.Plasma adiponectin— an independent indicator of liver fataccumulation /P. Pisto, O. Ukkola, M. Santaniemi et al. // Metabolism. – 2011. –Vol.60(11). – P.1515–20.223. Pocobelli, G. Statin use and risk of breast cancer /G. Pocobelli, P. Newcomb,A. Trentham-Dietz et al. // Cancer. – 2008. - Vol.112.
– Р.27-33.224. Polak, K. New markers of insulin resistance in polycystic ovary syndrome /K.Polak, A. Czyzyk, T. Simoncini, B. Meczekalski // J. Endocrinol. Invest. – 2017. Vol.40(1). – Р.1-8.225. Popovska-Dimova, Z. The frequency of insulin resistance calculated upon thebasis of a fasting glucose to insulin ratio and characteristics of insulin resistantwomen with polycystic ovary syndrome /Z.
Popovska-Dimova, B. Krstevska //Prilozi. – 2006. - Vol.27(1). – Р.87-95.226. Practice Committee of American Society for Reproductive Medicine. Obesityand reproduction: an educational bulletin // Fertil Steril. – 2008. – Vol.90 (Suppl 5). –P.21–29.141227. Primeau, V. Characterizing the profile of obese patients who are metabolicallyhealthy /V. Primeau, L. Coderre, A. Karelis et al.
// Int J Obes (Lond). – 2011. Vol.35(7). - Р.971-981.228. Purcell, S.H. The impact of obesity on egg quality /S.H. Purcell, K.H. Moley //J. Assist. Reprod. Genet. – 2011. – Vol.28(6). – P.517-524.229. Rachon, D. Ovarian function and obesity: interrelationship, impact on women’sreproductive lifespan and treatment options /D. Rachon, H. Teede // Mol.
CellEndocrinol. – 2010. - Vol.316. –Р.172–179.230. Rak-Mardyla, A. Ghrelin role in hypothalamus-pituitary-ovarian axis /A. RakMardyla // J. Physiol. Pharmacol. – 2013. – Vol.64(6). – P.695-704.231. Reid, S.P. Ovarian morphology is associated with insulinresistance in womenwith polycystic ovary syndrome: a cross sectional study /S.P. Reid, C.N. Kao, L.Pasch et al.
// Fertil. Res. Pract. – 2017. - Vol.3. – Р.8.232. Ren, J. The insulin-like growth factor I system: physiological andpathophysiologicalimplicationincardiovasculardiseasesassociatedwith metabolic syndrome /J. Ren, P. Anversa // Biochem Pharmacol. – 2015. –Vol.93(4). – P.409-417.233. Repaci, A. Ghrelin and reproductive disorders /A. Repaci, A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
